Evidence map›Paper›PMID 36973744›Full record

ReviewJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance2023

Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.

Vanessa M Ferreira, Sven Plein, Timothy C Wong, Qian Tao, Zahra Raisi-Estabragh, Supriya S Jain, Yuchi Han, Vineeta Ojha, David A Bluemke, Kate Hanneman and 5 more

Full text readConsensus StatementReview
In one paragraph

Review in Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Competency based curriculum for cardiovascular magnetic resonance: A position statement of the Society for Cardiovascular Magnetic Resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2024
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Prospective electrocardiographic and cardiovascular magnetic resonance alterations in the UK Biobank coronavirus disease 2019 repeat imaging study.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Article
  8. Abnormal coronary vascular response in patients with long COVID syndrome - a case-control study using oxygenation-sensitive cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Observational
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Impactful Cardiac CT and MRI Articles from 2023.Radiology. Cardiothoracic imaging · 2024
    Review
  16. Article
  17. MRI of cardiac involvement in COVID-19.The British journal of radiology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vanessa M FerreiraUniversity of Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Oxford British Heart Foundation Centre of Research Excellence, The National Institute for Health Research Oxford Biomedical Research Centre at the Oxford University Hospitals NHS Foundation Trust, Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Sven PleinDepartment of Biomedical Imaging Science, University of Leeds, Leeds, UK.
Timothy C WongDivision of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, USA.
Qian TaoDepartment of Imaging Physics, Delft University of Technology, Delft, The Netherlands.
Zahra Raisi-EstabraghWilliam Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Supriya S JainDivision of Pediatric Cardiology, Department of Pediatrics, Maria Fareri Children's Hospital at Westchester Medical Center, New York Medical College, New York, USA.
Yuchi HanCardiovascular Medicine, Wexner Medical Center, The Ohio State University, Columbus, USA.
Vineeta OjhaDepartment of Cardiovascular Radiology and Endovascular Interventions, All India Institute of Medical Sciences, New Delhi, India.
David A BluemkeDepartment of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, USA.
Kate HannemanDepartment of Medical Imaging, Toronto General Hospital, University of Toronto, Toronto, Canada.
Jonathan WeinsaftDepartment of Medicine, Division of Cardiology, Weill Cornell Medicine/New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA.
Mahesh K VidulaDivision of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA.
Ntobeko A B NtusiDivision of Cardiology, Department of Medicine, University of Cape Town and Groote Schuur Hospital; Cape Heart Institute, University of Cape Town, South African Medical Research Council Extramural Unit On Intersection of Noncommunicable Diseases and Infectious Diseases, Cape Town, South Africa.
Jeanette Schulz-MengerWorking Group on Cardiovascular Magnetic Resonance, Experimental and Clinical Research Center, a joint cooperation between Charité and MDC, Charité University Medicine, Berlin, Germany.
Jiwon KimDepartment of Medicine, Division of Cardiology, Weill Cornell Medicine/New York Presbyterian Hospital, Weill Cornell Medical College, New York, USA. jik9027@med.cornell.edu.ORCID http://orcid.org/0000-0002-8420-8604

Funding

Cardiac Magnetic Resonance for Tissue Characterization Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 SurvivorsR01HL159055 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KIM, JIWON · 2021 to 2025
$3.4M
Imaging-based Indentification of Premature Ventricular Contraction-mediatedR01HL148103 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI HAN, YUCHI · 2020 to 2025
$2.8M
Advanced CMR Tissue-Based Prediction of Right Ventricular Dysfunction and Revascularization ResponseK23HL140092 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI KIM, JIWON · 2018 to 2022
$847k
British Heart Foundation CH/16/1/32013British Heart Foundation CH/16/2/32089British Heart Foundation FS/17/81/33318British Heart Foundation SP/17/16/33519NHLBI NIH HHS K23 HL140092NHLBI NIH HHS R01 HL148103NHLBI NIH HHS R01 HL159055
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has affected nearly 600 million people to date across the world. While COVID-19 is primarily a respiratory illness, cardiac injury is also known to occur. Cardiovascular magnetic resonance (CMR) imaging is uniquely capable of characterizing myocardial tissue properties in-vivo, enabling insights into the pattern and degree of cardiac injury. The reported prevalence of myocardial involvement identified by CMR in the context of COVID-19 infection among previously hospitalized patients ranges from 26 to 60%. Variations in the reported prevalence of myocardial involvement may result from differing patient populations (e.g. differences in severity of illness) and the varying intervals between acute infection and CMR evaluation. Standardized methodologies in image acquisition, analysis, interpretation, and reporting of CMR abnormalities across would likely improve concordance between studies. This consensus document by the Society for Cardiovascular Magnetic Resonance (SCMR) provides recommendations on CMR imaging and reporting metrics towards the goal of improved standardization and uniform data acquisition and analytic approaches when performing CMR in patients with COVID-19 infection.

Indexed as

COVID-19Heart DiseasesMagnetic Resonance ImagingHeartHumansMagnetic Resonance SpectroscopyMyocarditisPredictive Value of TestsCardiac complicationsCardiovascular magnetic resonanceCOVID-19Diagnostic criteriaMicroinfarctionsMultisystem inflammatory syndromeMyocardial infarctionMyocarditisSARS-CoV-2Thrombotic complications

Identifiers

PMID36973744
PMCPMC10041524

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read3
measurements read23
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.